Cargando…
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of extremely preterm infants born each year. Despite the advances made in understanding the pathogenesis of this disease over the last five decades, BPD remains one of the major causes of morbidity and mortality in this...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959440/ https://www.ncbi.nlm.nih.gov/pubmed/35356441 http://dx.doi.org/10.3389/fped.2022.820259 |